RecruitingNot ApplicableNCT07660250

Vagus Nerve Stimulation for Myelopathy

Vagus Nerve Stimulation to Improve Post-operative Outcomes of Degenerative Cervical Myelopathy

Sponsor

Washington University School of Medicine

Enrollment

36 participants

Start Date

Apr 14, 2026

Study Type

INTERVENTIONAL

Conditions

Degenerative cervical myelopathy

Summary

The objective of this study is to generate preliminary data to establish the feasibility and effectiveness of transauricular vagus nerve stimulation (taVNS) to improve post-operative outcomes of moderate to severe degenerative cervical myelopathy (DCM)

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sham Stimulation and a medical device called Vagus nerve stimulation (taVNS) for people with degenerative cervical myelopathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVagus nerve stimulation (taVNS)

Vagus nerve stimulation - clip is attached to ear

DEVICESham Stimulation

Clip will be attached to the ear, but no stimulation will be given.

Locations(1)

Washington University

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07660250